The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App 
Professionals >> Visit The Body PROThe Body en Espanol
  • Email Email
  • Comments Comments
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

Medical News

Canada: Grant From Gates Foundation Will Aid Development of Revolutionary New Contraceptive

November 10, 2010

An Ottawa scientist has been awarded a $100,000 grant from the Bill & Melinda Gates Foundation to help develop a vaginal contraceptive that also protects against HIV and other STDs. The recipient is Dr. Nongnuj Tanphaichitr, a senior scientist in reproductive biology at the Ottawa Hospital Research Institute and a professor at the University of Ottawa Medical School. Working with her team, Tanphaichitr recently identified a natural antimicrobial peptide that appears to be able to inactivate sperm, viruses, and bacteria. Called LL-37, the peptide is naturally present in human semen, but in an inactive form. In contrast, most existing spermicidal products are chemical detergents that can be toxic and increase the risk of disease transmission. Tanphaichitr proposes delivering the active peptide via a vaginal ring that would release it slowly during an extended period of time. The grant is one of 65 announced in the fifth round of the foundation's Grand Challenges Exploration. Grantees were selected from among 2,400 applicants.

Back to other news for November 2010

Adapted from:
Ottawa Citizen

  • Email Email
  • Comments Comments
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

This article was provided by CDC National Prevention Information Network. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update.
See Also
More News and Research on Microbicides

No comments have been made.

Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read's Comment Policy.)

Your Name:

Your Location:

(ex: San Francisco, CA)

Your Comment:

Characters remaining: